April 2011
NASSCOM and KPMG Announce the Winners of the Healthcare IT Awards 2011
Acknowledging the Transformative Role of IT in Healthcare in India Hyderabad, April 22, 2011: National Association of Software and Services Companies (NASSCOM) in collaboration with KPMG today announced the winners of the first Healthcare IT Awards 2011 which were presented at Hyderabad today. The awards are aimed at giving centre stage to various initiatives and […]
Dr. Rajeswari Mahadevan awarded PhD
Dr. Rajeswari Mahadevan, in charge of the Department of Contact Lenses at Sankara Nethralaya, has been awarded a PhD in optometry. Dr. Rajeswari completed her PhD on the topic “study of Rigid Gas Permeable Contact Lenswearers for Keratoconus & Contact Lens Fitting Methods in Irregular Cornea’s” under the supervision and guidance of Dr.Prema Padmanabhan Director […]
Seva Rathna for Dr. Badrinath
The Srirangam Srimad Andavan Asramam honoured Sankara Nethralaya’s founder and Chairman Emeritus, Dr.SS Badrinath, with the Seva Rathna on April 10, 2011 at a function held in Chennai. Dr. Badrinath was presented the award in recognition of his relentless battle to eradicate blindness, his leadership and pioneering role in providing quality and affordable eye care […]
MCI mulls sending doctors back to school
Medical Council of India (MCI) is all set to send doctors back to lecture halls, failing which they would lose their license to practice. According to the new rules, which will be announced on Tuesday, MCI is planning to make it mandatory for all doctors to attend 30 hours of continuing medical education (CME) every […]
Reliving the leelas of Radha and Krishna
A soulful performance by Hiren Parpani and his troupe from Mumbai brought to life the leelas of Radha and Krishna in the ‘City of joy’. Sathavaro Radhe Shyamno, a benefit dance drama, in aid of Sankara Nethralaya, was held at the Science City Auditorium in Kolkata, on April 2 & 3, 2011. Considering the growing […]
Glenmark arm discovers molecule to treat blood cancer
Glenmark Pharmaceuticals today said it has discovered a new drug molecule which can treat blood and lymph cancer, besides inflammatory disorders. The novel biological entity, (NBE) ‘GBR 401’, was discovered by the company’s Switzerland-based arm Glenmark Pharmaceuticals SA, the company said in a statement. Read more…